Wellvone Tablets

(atovaquone)

What is Wellvone?

The name of your medicine is Wellvone. It contains the active ingredient atovaquone. Wellvone tablets are pale yellow and are marked with "WELLCOME" and "P7F". Each tablet contains 250 mg atovaquone.

There are also some inactive ingredients in Wellvone which are needed to make up the tablet. These are: hydroxypropyl cellulose, microcrystalline cellulose, povidone, sodium starch glycollate, magnesium stearate, hypromellose, titanium dioxide, polyethylene glycol and yellow iron oxide.

Wellvone comes in bottles of 189 tablets, as this is the number needed for a standard 21 day course.

Who makes Wellvone?

The Wellcome Foundation Limited, London, NW1 2BP makes Wellvone and is licensed to sell it in the UK.

The company licensed to sell Wellvone in the Republic of Ireland is Wellcome Ireland Limited, Dublin.

What is Wellvone used for?

Wellvone is an anti-parasitic medicine. It is used to treat infection caused by a single-celled organism called Pneumocystis carinii (PCP).

What should I check before taking Wellvone?

Ask yourself these questions to check whether Wellvone is right for you:

If the answer is "YES" to any of these questions, tell your doctor.

What if I am taking other medicines?

Always tell your doctor about any medicines you are taking, including those you can buy yourself. Some medicines can stop Wellvone working properly; these are:

Wellvone can affect the action of some medicines; these are:

How do I take Wellvone?

Does Wellvone have side-effects?

Wellvone can cause side-effects in some people. These are:

Tell your pharmacist or doctor if you get these or any other any other side-effects from your

medicine which are not mentioned here.

Is there anything else I should know?

Keep your Wellvone tablets in a safe place where children cannot see or reach them.

This leaflet was last revised in July 1994

Wellvone is a Trade mark of The Wellcome Foundation Limited.

 

 

 

 

 

 

 

 

0/5773 94.10